Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Why Tessera Believes Its Gene Writing Platform Can Go Way Beyond CRISPR
Interview: Bio-Entrepreneur On The Hunt For The Definitive Genetic Medicine Platform
Sep 29 2022
•
By
Andrew McConaghie
The company was established four years ago, and will soon be ready to share its initial data with the world. • Source: Shutterstock
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from Gene Therapies
More from Advanced Therapies